Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

301 to 308 of 308 results

AstraZeneca unit in-licenses Pfizer drug candidate tremelimumab

04-10-2011

Anglo-Swedish drug major AstraZeneca’s (LSE: AZN) US biologics subsidiary MedImmune has in-licensed…

AstraZenecaLicensingMedImmuneOncologyPfizerPharmaceutical

AstraZeneca in patent settlement deal with Handa over Seroquel XR

30-09-2011

Anglo-Swedish drug major AstraZeneca (LSE: AN) yesterday revealed that it has entered into a settlement…

AstraZenecaGenericsHanda PharmaceuticalsNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

AstraZeneca/MedImmune’s tralokinumab shows positive impact on pulmonary function in patients with uncontrolled asthma

19-09-2011

The addition of tralokinumab to existing asthma controller medication resulted in an improvement in lung…

AstraZenecaMedImmunePharmaceuticalResearchRespiratory and Pulmonarytralokinumab

UK’s NICE backs AstraZeneca’s new “clot-busting” drug Brilique to treat ACS

16-09-2011

In final draft guidance published today, the UK drugs watchdog the National Institute of Health and Clinical…

AstraZenecaBrilintaBriliqueCardio-vascularEuropePharmaceuticalRegulation

AstraZeneca’s Crestor fails to show significant improvement over Lipitor

05-09-2011

There was a big disappointment for Anglo-Swedish drug major AstraZeneca (LSE: AZN) on Friday, when it…

AstraZenecaCardio-vascularCrestorLipitorPfizerPharmaceuticalResearch

AstraZeneca’s Brilinta shows mortality benefit over gold-standard Plavix

30-08-2011

There was good news for Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday, when the firm revealed…

AstraZenecaBrilintaCardio-vascularPharmaceuticalPlavixResearchSanofi

301 to 308 of 308 results

Back to top